Coloplast full year report 2008/09: EBIT-margin up 4%-points

Coloplast’s full year announcement reveals a vast increase in profitability. In 2008/09, the company realised EBIT of DKK 1,395m equal to an EBIT margin of 16% against 12% last year. In Q4, 2008/09 profit was DKK 406m equal to an EBIT margin of 18%.

“We have become more efficient and more profitable during the year, so I am very pleased with the results, especially the Q4 is very strong,” says Lars Rasmussen, President & CEO.

In line with Coloplast’s expectations, the 2008/09 organic revenue growth was 6%, which is also the general market growth. Q4 growth was 7%.

“I’m pleased with the strong increase in profitability, but we still want higher growth. Now that we have profit under control we have a solid basis for fulfilling that ambition,” says Lars Rasmussen.

In 2009/10 Coloplast expects an organic revenue growth of 6-7%. Based on constant exchange rates revenue growth in DKK is expected to be 4-5%. Coloplast expects an EBIT margin in constant exchange rates of 17-18% and in DKK of 16-17%.